TW202140421A - 苯衍生物的新穎晶形 - Google Patents

苯衍生物的新穎晶形 Download PDF

Info

Publication number
TW202140421A
TW202140421A TW110103260A TW110103260A TW202140421A TW 202140421 A TW202140421 A TW 202140421A TW 110103260 A TW110103260 A TW 110103260A TW 110103260 A TW110103260 A TW 110103260A TW 202140421 A TW202140421 A TW 202140421A
Authority
TW
Taiwan
Prior art keywords
degrees
powder
compound according
compound
ray diffraction
Prior art date
Application number
TW110103260A
Other languages
English (en)
Chinese (zh)
Inventor
大谷修平
藤戸貴之
西馬直希
Original Assignee
日商小野藥品工業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商小野藥品工業股份有限公司 filed Critical 日商小野藥品工業股份有限公司
Publication of TW202140421A publication Critical patent/TW202140421A/zh

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW110103260A 2020-01-29 2021-01-28 苯衍生物的新穎晶形 TW202140421A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020012075 2020-01-29
JP2020-012075 2020-01-29

Publications (1)

Publication Number Publication Date
TW202140421A true TW202140421A (zh) 2021-11-01

Family

ID=77079390

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110103260A TW202140421A (zh) 2020-01-29 2021-01-28 苯衍生物的新穎晶形

Country Status (4)

Country Link
JP (1) JPWO2021153690A1 (ja)
KR (1) KR20220132537A (ja)
TW (1) TW202140421A (ja)
WO (1) WO2021153690A1 (ja)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016254A1 (fr) * 2001-08-09 2003-02-27 Ono Pharmaceutical Co., Ltd. Composes derives d'acide carboxylique et medicaments comprenant ces composes comme principe actif
UA99927C2 (uk) * 2007-11-12 2012-10-25 Ацьенде Кимике Риуните Анджелини Франческо А.Чи.Р.А.Ф. С.П.А. Медикамент, який є активним при невропатичному болі
AU2019313082B2 (en) * 2018-07-31 2024-05-30 Ono Pharmaceutical Co., Ltd. Benzene derivative

Also Published As

Publication number Publication date
WO2021153690A1 (ja) 2021-08-05
KR20220132537A (ko) 2022-09-30
JPWO2021153690A1 (ja) 2021-08-05

Similar Documents

Publication Publication Date Title
EP1074542B1 (en) Sulfonamide-containing indole compounds
WO2022268230A1 (zh) 作为kif18a抑制剂的化合物
BR112016018341B1 (pt) Composto de triazina, seu uso para propósitos médicos, composição farmacêutica, inibidor de mpges1 e agente profilático ou terapêutico
EA027451B1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и их применение
JPH08169884A (ja) シクロプロパクロメンカルボン酸誘導体
TW201625533A (zh) Ｋｃｎｑ ２至５通道活化劑
Feng et al. Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy
CN110305045A (zh) 一种酰胺类化合物及其在治疗癌症中的用途
CN109651208B (zh) N-芳基磺酰胺类化合物，其药物组合物及其用途
TWI823420B (zh) 用作cdk激酶抑制劑的化合物及其應用
TW202019876A (zh) 苯衍生物
CN103848795B (zh) 一种1,2,5-噁二唑-2-氧化物组蛋白去乙酰化酶抑制剂及其制备方法和应用
EP4110781B1 (en) 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
JP2005532280A (ja) 化合物
TW202140421A (zh) 苯衍生物的新穎晶形
JP2013512216A (ja) 置換ピラゾロピリミジン類の結晶形
WO2023274280A1 (zh) 一种联苯类衍生物抑制剂的晶型及其制备方法
CN113956236B (zh) 邻苯二甲酰亚胺类化合物及其用途
TW201922690A (zh) 環－amp反應元素結合蛋白的抑制劑
WO2018068357A1 (zh) 一类新型sirt2蛋白抑制剂及其在制药中的用途
US9403803B2 (en) Indole-3-carboxamides as kinase inhibitors
CN109071503A (zh) 用于抑制亲环素的化合物及其用途
KR102597986B1 (ko) 3-(3,5-디클로로-4-히드록시벤조일)-1,1-디옥소-2,3-디히드로-1,3-벤조티아졸의 결정형 및 염
EP3447045B1 (en) 1-(1-hydroxy-2,3-dihydro-1h-inden-5-yl)-urea derivatives and related compounds kcnq 2-5 channel activators for treating dysuria
CN101115734A (zh) 作为脂氧化酶抑制剂的螺环衍生物